Agios Pharm (AGIO) Insider Trading
- $153,404,205.75
- $155,562,864.87
- Sept. 26, 2024
- Scott Biller
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 13, 2019 | CEO | 40,322 | $31.00 | Buy | $1,249,982.00 | |
Nov. 12, 2019 | Major Shareholder | 403,225 | $31.00 | Buy | $12,499,975.00 | |
April 5, 2019 | Insider | 3,000 | $67.71 | Sell | $203,130.00 | |
April 1, 2019 | Insider | 10,000 | $66.57 | Sell | $665,700.00 | |
March 15, 2019 | Insider | 10,000 | $64.16 | Sell | $641,600.00 | |
March 4, 2019 | Insider | 10,000 | $67.01 | Sell | $670,100.00 | |
Feb. 27, 2019 | Insider | 9,000 | $65.00 | Sell | $585,000.00 | |
Nov. 5, 2018 | Insider | 3,000 | $69.69 | Sell | $209,070.00 | |
Oct. 5, 2018 | Insider | 3,000 | $69.79 | Sell | $209,370.00 | |
Sept. 11, 2018 | Director | 13,555 | $72.75 | Sell | $986,126.25 | |
Sept. 5, 2018 | Insider | 3,000 | $83.07 | Sell | $249,210.00 | |
Aug. 30, 2018 | Insider | 1,700 | $80.03 | Sell | $136,051.00 | |
Aug. 24, 2018 | Insider | 2,050 | $74.92 | Sell | $153,586.00 | |
Aug. 6, 2018 | Insider | 3,000 | $80.11 | Sell | $240,330.00 | |
July 25, 2018 | Insider | 2,050 | $84.58 | Sell | $173,389.00 | |
July 9, 2018 | Insider | 272 | $84.94 | Sell | $23,103.68 | |
July 5, 2018 | Insider | 3,000 | $83.50 | Sell | $250,500.00 | |
June 22, 2018 | Insider | 2,050 | $97.58 | Sell | $200,039.00 | |
June 14, 2018 | Director | 9,000 | $93.55 | Sell | $841,950.00 | |
June 12, 2018 | Insider | 2,000 | $92.89 | Sell | $185,780.00 | |
June 5, 2018 | Insider | 3,000 | $93.37 | Sell | $280,110.00 | |
June 1, 2018 | CEO | 13,000 | $95.35 | Sell | $1,239,550.00 | |
May 30, 2018 | CEO | 45,626 | $90.07 | Sell | $4,109,533.82 | |
May 23, 2018 | CEO | 49,374 | $90.40 | Sell | $4,463,409.60 | |
May 23, 2018 | Insider | 15,177 | $90.00 | Sell | $1,365,930.00 | |
May 7, 2018 | Insider | 3,000 | $81.81 | Sell | $245,430.00 | |
May 1, 2018 | CEO | 13,000 | $83.04 | Sell | $1,079,520.00 | |
April 23, 2018 | Insider | 2,050 | $85.95 | Sell | $176,197.50 | |
April 12, 2018 | Insider | 2,000 | $85.10 | Sell | $170,200.00 | |
April 5, 2018 | Insider | 3,000 | $75.20 | Sell | $225,600.00 | |
April 2, 2018 | CEO | 13,000 | $77.72 | Sell | $1,010,360.00 | |
March 22, 2018 | Insider | 2,050 | $84.65 | Sell | $173,532.50 | |
March 19, 2018 | Director | 6,800 | $81.97 | Sell | $557,396.00 | |
March 16, 2018 | Director | 200 | $83.44 | Buy | $16,688.00 | |
March 5, 2018 | Insider | 3,000 | $83.08 | Sell | $249,240.00 | |
March 1, 2018 | CEO | 13,000 | $81.09 | Sell | $1,054,170.00 | |
Feb. 22, 2018 | Insider | 2,050 | $78.63 | Sell | $161,191.50 | |
Feb. 16, 2018 | Insider | 2,000 | $77.65 | Sell | $155,300.00 | |
Feb. 5, 2018 | Insider | 3,000 | $76.04 | Sell | $228,120.00 | |
Feb. 1, 2018 | Insider | 2,000 | $78.75 | Sell | $157,500.00 | |
Feb. 1, 2018 | CEO | 13,000 | $78.75 | Sell | $1,023,750.00 | |
Jan. 26, 2018 | CEO | 23,572 | $81.09 | Sell | $1,911,453.48 | |
Jan. 24, 2018 | CEO | 46,408 | $80.01 | Sell | $3,713,104.08 | |
Jan. 23, 2018 | Insider | 25,000 | $74.83 | Sell | $1,870,750.00 | |
Jan. 23, 2018 | Major Shareholder | 851,154 | $67.00 | Buy | $57,027,318.00 | |
Jan. 16, 2018 | CEO | 53,000 | $73.16 | Sell | $3,877,480.00 | |
Jan. 12, 2018 | Insider | 2,150 | $75.00 | Sell | $161,250.00 | |
Jan. 10, 2018 | Insider | 3,000 | $65.00 | Sell | $195,000.00 | |
Dec. 7, 2017 | Director | 3,838 | $59.37 | Sell | $227,862.06 | |
Dec. 1, 2017 | Insider | 2,146 | $60.79 | Sell | $130,455.34 |
Insiders are both buying and selling Agios Pharm stock.
The insider traders at Agios Pharm are: Scott Biller, David P Schenkein, Lewis Clayton Jr. Cantley, John Duncan Higgons, Glenn Goddard, Christopher Bowden, Steven L Hoerter, Theodore James Jr. Washburn, Carman Alenson, Brian Goff, Jacqualyn A Fouse, James William Burns, John Maraganore, Cecilia Jones, Kaye I Foster-Cheek, Celgene European Investment Co, Robert Nelsen, Darrin Miles, Corp /De/ Celgene, Tsveta Milanova, Sarah Gheuens, and David Scadden
The most active insider trader at Agios Pharm is Scott Biller with 46 trades.
David P Schenkein has sold the most Agios Pharm stock with a total value of $52,693,359.25.
Celgene European Investment Co has bought the most Agios Pharm stock with a total value of $112,876,552.75.
The most recent insider trade for Agios Pharm was on Sept. 26, 2024.
The single biggest insider buy for Agios Pharm was from Corp /De/ Celgene with a total value of $57,027,318.00 on Jan. 23, 2018.
The single biggest insider sell for Agios Pharm was from Robert Nelsen with a total value of $11,998,527.52 on Feb. 28, 2017.